EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS095-08084 
Organism
Homo sapiens 
Tissue/cell
HMEC 
Coordinate
chr12:133021470-133023280 
TF binding sites/motifs
Number: 26             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC-6.92
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC-6.74
JDP2(var.2)MA0656.1chr12:133022644-133022656TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022745-133022757TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022695-133022707GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022796-133022808GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022847-133022859GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022897-133022909GATGACGTCACC+6.92
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10775chr12:133020028-133023469CD19_Primary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr12133021598133021727
chr12133021781133022391
chr12133021534133022956
Number: 1             
IDChromosomeStartEnd
GH12I132443chr12133020139133023744
Enhancer Sequence
CCAAGGCTGC GTTTCCCTCG CCCCCACCCC AGTCCCCCGC GTTGGTAGTG GGATCGGTTT 60
GGTATTCTGA GGCTTCTCTC ATTTCTCCTT TATCACCATC TGCCCCACAG CAGGCAGGCC 120
CGGAGCCTCT GCAGAAGGGG GAACCGGGTG CAGGCCCAAC GCCGGTCTCT CAGTGTGGCA 180
GCCTTGCGCG CGAGCAGAAG CAGAAGGCCT AGTTCCTACT CTGCAGCCTT GGCTGCCGGG 240
CACGGAGAAC GTTTTAGCAG AAACACCTCT GCAAAACCAC TTCCTGGCCC GGGCCCAGCC 300
AAACACCATC TTCTCCTCCA CCCCAGGGCT CCGCCCCCAT CTCCAGGCTC AGCCCAGCAC 360
CCCCACCCCC GAAACCCCCA GCCCCACTGC ATCTGCCCTG GCCATCTGCC TCCGCCCTGC 420
CTCGCTAACA CAGTTATTAA TGAGCAATTT TCCTGTAATT ACAACGCAGT TATGCCAGTT 480
ACCCCGACCT GCTGACAGAG AGCATTCACT TCCATGTGGC ACTAGCCCCC AGGCCTGAGA 540
GGACGCAAAC ACTTGCCCCT CATTCGCTGC CCCCACCCCC ACTCTGCCAG CCAGCACCAC 600
CCTCCACCCA CTCTAGGCCC TTAAGAAAGG AGGGAAGGGC CGCGGGGAGG AGCTCTCAGA 660
TCCCGAGGCC CCACTCCCCC TGCAAGGAAG GCTGTGAGCT CGGCCCCAGC CCACCTGCCA 720
GCTCCCCAAA CACCTCCCAC CTCCCTCCGC CGCCTCCTGA AGGGACTACA CTCCCCTGGC 780
TCCTCCAAAA TCCGCTAATG AACAGCAGGC GCAGAGGCTC CGCCACCGGC GTGCTCCTGG 840
CCTCAGCCCT CCCTGTTCTG AAACCGCCTT TGCTAAGACG GTAGTAGTGA GGAATCACGA 900
CAGTGGCAGA GGCCAACCTG ACCCGCTCCA CCTGCCTCCA CCCCAACCCG CCCGGCTGCT 960
TCCTGAGCGT GGGCCAAACT AACTTTGACA GGAACTTAGT TTACAGTTTA AGTTGGGAAC 1020
AAAAAGGATA ACAGCCCCTC CCCAAAACAG ATTCCCTCCT CGCTTGGGGG GACCAGTCCC 1080
GTTGTAAAAC CGACAAATAA CAGCAGGATT AGGAATTCCG GCTCAGGATT CACGCAGCCA 1140
GACGCCACAG GACTCCTCCC CAGCCGCTCC TGTATATGAC GTCACCGCCG TAAGACCACA 1200
GGACACCGCC CCAGCCGCGC CTGTAGATGA CGTCACCATC GTAAGACCAC AGGACCCTTC 1260
CCAGCCGCTC CTGTATATGA CGTCACCGCC GTAAGACCAC AAGTCACCGC CCCAGCCGCT 1320
CCTGTAGATG ACGTCACCAC AGTAAGACCA CAGGATACCG CCCCAGCCGC GCCTGTAGAT 1380
GACGTCACCA TCGTAGGCCC ACAGGACCCT TCCCAGCCGC TCCTGTGGAT GACGTCACCG 1440
CCGTAGGACC TAAGATTGAT GCTGGAGAGG TTCTTCAGAC CCTGCGTTCT GACGGCTCCG 1500
CTGGCACCAC CCAGACGGGT AAACTAGCTC TTCCGGTCTG TGGCCCTCAC AGGAACCGAC 1560
TCGGTGCAGG AGGACAGCTT CAGCCCCTGT GATTTCATCC CCGACCAACC AGCCAGCACT 1620
CCCCACTCCC TAGCCCCCTG CCTGCCAAAC TATCTTTTAA AAAACTCCAG TTTCCAAATT 1680
TTCAGGGAGG CTGATTTGAG TAATAATAAA ACTCCAGTCT CCTGCTAGCT GGCTCTGGAT 1740
GCACTAGACT CTATTGCAAT TCTCCTGTCC TGATAAATCG GCTGTCAGGC AAGAAGAACC 1800
CGTTGGGTGG 1810